A new biotechnology company in McKinney has ambitions to become the world’s first fully integrated platform for polymerase chain reaction (PCR) testing — the same technology behind a common COVID-19 ...
Covering both mosquito-borne diseases and emerging respiratory pathogens, Anbio continues to advance point-of-care diagnostics for timely outbreak detection worldwide. FRANKFURT, Germany, Aug. 8, 2025 ...
Given the highly infectious nature of the COVID pathogen, tests for the virus had to be quick, reliable and safe. The test ...
FRANKFURT, Germany, Aug. 08, 2025 (GLOBE NEWSWIRE) -- In response to recent outbreaks of Chikungunya fever, Anbio Biotechnology (NNNN) has announced the launch of its Chikungunya IgM/IgG Rapid Test, ...
The MarketWatch News Department was not involved in the creation of this content. Covering both mosquito-borne diseases and emerging respiratory pathogens, Anbio continues to advance point-of-care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results